SCHEMBL8338276

SCHEMBL8338276

CCCC(CCC(C(=O)NC(=O)NC)c1ccc(OC)cc1)N=S(=O)=O

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TAS1R3 Q7RTX0 2/20 0.37
▸ TAS1R1 Q7RTX1 2/20 0.37
▸ CYP1A2 P05177 1/20 0.36
▸ CYP3A4 P08684 1/20 0.36
▸ CYP2C9 P11712 1/20 0.36
▸ PKM P14618 1/20 0.36
▸ CYP2C19 P33261 1/20 0.36
▸ MMP9 P14780 3/20 0.36
▸ MMP13 P45452 3/20 0.36
▸ MMP1 P03956 3/20 0.36
▸ ADAM17 P78536 2/20 0.36
▸ CNR2 P34972 2/20 0.34
▸ CNR1 P21554 1/20 0.34
▸ SLC6A2 P23975 1/20 0.34
▸ SLC6A4 P31645 1/20 0.34
▸ SLC6A3 Q01959 1/20 0.34
▸ GPR88 Q9GZN0 2/20 0.33
▸ KCNQ2 O43526 1/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ RAB9A P51151 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8340431 0.94 MMP9 (0.39) TAS1R3TAS1R1CYP1A2CYP3A4CYP2C9
SCHEMBL8337089 0.93 MMP9 (0.43) TAS1R3TAS1R1CYP1A2CYP3A4CYP2C9
SCHEMBL8336514 0.93 PKM (0.37) CYP1A2CYP3A4CYP2C9PKMCYP2C19
SCHEMBL8336849 0.92 MMP9 (0.44) CYP1A2CYP3A4CYP2C9PKMCYP2C19
SCHEMBL8338207 0.90 TDP1 (0.37) TAS1R3TAS1R1CYP1A2CYP3A4CYP2C9
SCHEMBL8341137 0.86 CYP1A2 (0.38) CYP1A2CYP3A4CYP2C9PKMCYP2C19
SCHEMBL8339304 0.84 MMP9 (0.42) MMP9MMP13MMP1ADAM17CNR2
SCHEMBL8334100 0.84 POLB (0.41) TAS1R3TAS1R1MMP9MMP13MMP1
SCHEMBL8338140 0.84 MMP9 (0.38) TAS1R3TAS1R1CYP1A2CYP3A4CYP2C9
SCHEMBL8334670 0.83 MMP9 (0.41) CYP1A2CYP3A4CYP2C9PKMCYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5977177-A Substituted benzenesulfonylureas and-thioureas, processes for their preparation and use of pharmaceutical preparations based on these compounds, and medicaments containing them HOECHST AKTIENGESELLSCHAFT (DE) 1999-11-02 — — US disclosed
US-5880155-A TREATMENT OF CARDIOVASCULAR DISORDERS HOECHST AKTIENGESELLSCHAFT (DE) 1999-03-09 — — US disclosed
Send feedback